Literature DB >> 31636093

Structural Mechanisms of PTEN Regulation.

Glenn R Masson1, Roger L Williams1.   

Abstract

The tumor suppressor phosphatase and tensin homolog on chromosome 10 (PTEN) is a tightly regulated enzyme responsible for dephosphorylating the progrowth lipid messenger molecule phosphatidylinositol 3,4,5-trisphosphate (PIP3) on the plasma membrane. The carboxy-terminal tail (CTT) of PTEN is key for regulation of the enzyme. When phosphorylated, the unstructured CTT interacts with the phosphatase-C2 superdomain to inactivate the enzyme by preventing membrane association. PTEN mutations associated with cancer also inactivate the enzyme. Alternate translation-initiation sites generate extended isoforms of PTEN, such as PTEN-L that has multiple roles in cells. The extended amino-terminal region bears a signal sequence and a polyarginine sequence to facilitate exit from and entry into cells, respectively, and a membrane-binding helix that activates the enzyme. This amino-terminal region also facilitates mitochondrial and nucleolar localization. This review explores PTEN structure and its impact on localization and regulation.
Copyright © 2020 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31636093      PMCID: PMC7050585          DOI: 10.1101/cshperspect.a036152

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  72 in total

1.  The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation.

Authors:  J Torres; R Pulido
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

2.  Computational Prediction of Amino Acids Governing Protein-Membrane Interaction for the PIP3 Cell Signaling System.

Authors:  William A Irvine; Jack U Flanagan; Jane R Allison
Journal:  Structure       Date:  2018-12-06       Impact factor: 5.006

3.  Ordered phosphorylation events in two independent cascades of the PTEN C-tail revealed by NMR.

Authors:  Florence Cordier; Alain Chaffotte; Elouan Terrien; Christophe Préhaud; François-Xavier Theillet; Muriel Delepierre; Monique Lafon; Henri Buc; Nicolas Wolff
Journal:  J Am Chem Soc       Date:  2012-12-07       Impact factor: 15.419

4.  The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate.

Authors:  T Maehama; J E Dixon
Journal:  J Biol Chem       Date:  1998-05-29       Impact factor: 5.157

5.  Conformational stability and catalytic activity of PTEN variants linked to cancers and autism spectrum disorders.

Authors:  Sean B Johnston; Ronald T Raines
Journal:  Biochemistry       Date:  2015-02-13       Impact factor: 3.162

Review 6.  Dual-specificity phosphatases: critical regulators with diverse cellular targets.

Authors:  Kate I Patterson; Tilman Brummer; Philippa M O'Brien; Roger J Daly
Journal:  Biochem J       Date:  2009-03-15       Impact factor: 3.857

7.  The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motif.

Authors:  Steven M Walker; Nick R Leslie; Nevin M Perera; Ian H Batty; C Peter Downes
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

8.  PTEN phosphatase selectively binds phosphoinositides and undergoes structural changes.

Authors:  Roberta E Redfern; Duane Redfern; Melonnie L M Furgason; Mary Munson; Alonzo H Ross; Arne Gericke
Journal:  Biochemistry       Date:  2008-01-26       Impact factor: 3.162

9.  Systematic analysis of the PTEN 5' leader identifies a major AUU initiated proteoform.

Authors:  Ioanna Tzani; Ivaylo P Ivanov; Dmitri E Andreev; Ruslan I Dmitriev; Kellie A Dean; Pavel V Baranov; John F Atkins; Gary Loughran
Journal:  Open Biol       Date:  2016-05-25       Impact factor: 6.411

10.  Interactions of phosphatase and tensin homologue (PTEN) proteins with phosphatidylinositol phosphates: insights from molecular dynamics simulations of PTEN and voltage sensitive phosphatase.

Authors:  Antreas C Kalli; Isabel Devaney; Mark S P Sansom
Journal:  Biochemistry       Date:  2014-03-10       Impact factor: 3.321

View more
  15 in total

1.  Estrogen receptor β and treatment with a phytoestrogen are associated with inhibition of nuclear translocation of EGFR in the prostate.

Authors:  Wan-Fu Wu; Li Wang; Nicholas Spetsieris; Myrto Boukovala; Eleni Efstathiou; Clemens Brössner; Margaret Warner; Jan-Ake Gustafsson
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

2.  Structural and Dynamic Effects of PTEN C-Terminal Tail Phosphorylation.

Authors:  Iris N Smith; Jennifer E Dawson; James Krieger; Stetson Thacker; Ivet Bahar; Charis Eng
Journal:  J Chem Inf Model       Date:  2022-08-24       Impact factor: 6.162

Review 3.  Allostery: Allosteric Cancer Drivers and Innovative Allosteric Drugs.

Authors:  Ruth Nussinov; Mingzhen Zhang; Ryan Maloney; Yonglan Liu; Chung-Jung Tsai; Hyunbum Jang
Journal:  J Mol Biol       Date:  2022-04-01       Impact factor: 6.151

4.  A-FABP-PTEN/AKT Regulates Insulin Resistance in Preadipocyte Cell 3T3-L1 Cells.

Authors:  Rensiqin Wu; Hui Wang; Jian Huangfu; Rui Xiao
Journal:  Diabetes Metab Syndr Obes       Date:  2021-05-11       Impact factor: 3.168

Review 5.  Phosphorylation and Driver Mutations in PI3Kα and PTEN Autoinhibition.

Authors:  Ruth Nussinov; Mingzhen Zhang; Chung-Jung Tsai; Hyunbum Jang
Journal:  Mol Cancer Res       Date:  2020-12-07       Impact factor: 6.333

Review 6.  PTEN Alterations and Their Role in Cancer Management: Are We Making Headway on Precision Medicine?

Authors:  Nicola Fusco; Elham Sajjadi; Konstantinos Venetis; Gabriella Gaudioso; Gianluca Lopez; Chiara Corti; Elena Guerini Rocco; Carmen Criscitiello; Umberto Malapelle; Marco Invernizzi
Journal:  Genes (Basel)       Date:  2020-06-28       Impact factor: 4.096

7.  Combined analysis of PTEN, HER2, and hormone receptors status: remodeling breast cancer risk profiling.

Authors:  Elham Sajjadi; Konstantinos Venetis; Roberto Piciotti; Donatella Gambini; Concetta Blundo; Letterio Runza; Stefano Ferrero; Elena Guerini-Rocco; Nicola Fusco
Journal:  BMC Cancer       Date:  2021-10-28       Impact factor: 4.430

8.  MiR-221/222 Ameliorates Deoxynivalenol-Induced Apoptosis and Proliferation Inhibition in Intestinal Epithelial Cells by Targeting PTEN.

Authors:  Lianjie Hou; Xiong Tong; Shuyun Lin; Mingfang Yu; Wen-Chu Ye; Meiying Xie
Journal:  Front Cell Dev Biol       Date:  2021-05-19

9.  The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane.

Authors:  Hyunbum Jang; Iris Nira Smith; Charis Eng; Ruth Nussinov
Journal:  iScience       Date:  2021-04-17

Review 10.  A Retrospective on eIF2A-and Not the Alpha Subunit of eIF2.

Authors:  Anton A Komar; William C Merrick
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.